Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2381-2387
Open Access | Times Cited: 261

Showing 1-25 of 261 citing articles:

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Gill Livingston, Jonathan Huntley, Kathy Liu, et al.
The Lancet (2024) Vol. 404, Iss. 10452, pp. 572-628
Closed Access | Times Cited: 559
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 496
Blood biomarkers for Alzheimer’s disease in clinical practice and trials
Oskar Hansson, Kaj Blennow, Henrik Zetterberg, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 506-519
Open Access | Times Cited: 220
Emerging diagnostics and therapeutics for Alzheimer disease
Wade Self, David M. Holtzman
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2187-2199
Closed Access | Times Cited: 184
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Bruna Bellaver, Guilherme Povala, Pâmela C.L. Ferreira, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1775-1781
Open Access | Times Cited: 166
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
Joseph Therriault, Marie Vermeiren, Stijn Servaes, et al.
JAMA Neurology (2022) Vol. 80, Iss. 2, pp. 188-188
Open Access | Times Cited: 155
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Davis Cammann, et al.
BioDrugs (2023) Vol. 38, Iss. 1, pp. 5-22
Open Access | Times Cited: 127
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1954-1963
Open Access | Times Cited: 118
Towards a future where Alzheimer’s disease pathology is stopped before the onset of dementia
Wiesje M. van der Flier, Marjolein E. de Vugt, Ellen M.A. Smets, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 494-505
Open Access | Times Cited: 114
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Bruno Dubois, Christine A. F. Von Arnim, Nerida Burnie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 85
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
Sebastian Palmqvist, Marcello Rossi, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1971-1978
Open Access | Times Cited: 78
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
Bruno Dubois, Nicolas Villain, Lon S. Schneider, et al.
JAMA Neurology (2024)
Closed Access | Times Cited: 61
Detection and treatment of Alzheimer’s disease in its preclinical stage
Michael S. Rafii, Paul Aisen
Nature Aging (2023) Vol. 3, Iss. 5, pp. 520-531
Closed Access | Times Cited: 59
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 55
Cellular and pathological functions of tau
C Bravo, Sarah Naguib, Li Gan
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 845-864
Closed Access | Times Cited: 36
Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums
Anita Kamondi, Madeleine Grigg‐Damberger, Wolfgang Löscher, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 3, pp. 162-182
Closed Access | Times Cited: 32
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation
C Bravo, Alice Maria Giani, Jesus Madero-Perez, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2446-2464.e22
Open Access | Times Cited: 26
Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology
Joseph Therriault, Nicholas J. Ashton, Ilaria Pola, et al.
EBioMedicine (2024) Vol. 102, pp. 105046-105046
Open Access | Times Cited: 25
Alzheimer disease blood biomarkers: considerations for population-level use
Michelle M. Mielke, Nicole R. Fowler
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 495-504
Closed Access | Times Cited: 24
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Fernándo González‐Ortiz, Bjørn‐Eivind Kirsebom, José Contador, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases
Linda Karlsson, Jacob W. Vogel, Ida Arvidsson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 2143-2154
Open Access | Times Cited: 17
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications
Susan Landau, JiaQie Lee, Alice Murphy, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 2113-2127
Open Access | Times Cited: 16
Proteomic changes in Alzheimer disease associated with progressive Aβ plaque and tau tangle pathologies
Alexa Pichet Binette, Chris Gaiteri, Malin Wennström, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 10, pp. 1880-1891
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top